Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

Exploratory analyses in very severe social anxiety disorder showed nominally statistically significant improvements based on recently reported clinical studies. However, the evidence is described as only “nominal,” suggesting early/limited confirmation rather than a definitive breakthrough. Net impact is likely modest until follow-up confirmatory results are available.

Analysis

Exploratory analyses in very severe social anxiety disorder showed nominally statistically significant improvements based on recently reported clinical studies. However, the evidence is described as only “nominal,” suggesting early/limited confirmation rather than a definitive breakthrough. Net impact is likely modest until follow-up confirmatory results are available.